Well-Ex NDC 68703-318

NDC codes

FDA NDC Directory

Product NDC (as listed)68703-318Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68703-0318Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68703-318-30	68703031830	180 TABLET in 1 BOTTLE, GLASS (68703-318-30)Marketed from Dec 17, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Well-Ex
Generic name (nonproprietary): arsenicum alb, graphites, hepar sulph calc, radium brom, viola tric
Active ingredients: Graphite — 6 [hp_C]/1Calcium sulfide — 6 [hp_C]/1Arsenic trioxide — 6 [hp_C]/1Radium bromide — 30 [hp_C]/1Viola tricolor — 6 [hp_C]/1
Dosage form: Tablet
Route: Oral
Labeler: Silver Star Brands
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Dec 17, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 68703-318_2868c35d-f750-32cc-e063-6394a90a72ddSPL ID 2868c35d-f750-32cc-e063-6394a90a72ddSPL set ID 81f617eb-7be0-ae44-e053-2991aa0ae196UNII 4QQN74LH4O, 1MBW07J51Q, S7V92P67HO, R74O7T8569, 9Q24RAI43VUPC 0818837014547

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468703031830 followed by a unit qualifier and the quantity

Package 68703-0318-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2024.

Indications (excerpt from the label)

Uses* Uses*: Soothes transient itching and weeping of skin during an eczema 'flare up'. *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)